GENTIAN DIAGNOSTICS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.6 NOK | -1.53% |
|
0.00% | -6.99% |
| Apr. 30 | Gentian Diagnostics ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 30 | Transcript : Gentian Diagnostics ASA, Q1 2024 Earnings Call, Apr 30, 2024 |
Evolution of the average Target Price on Gentian Diagnostics
Price target over the last 5 years
History of analyst recommendation changes
db0a5c8c70b4d6ad22ee52a.NuTMAkYI8RscVolCWLnr-pbC7I9KqzuXQcZLouE7Cc8.Bdy7Tz9_vUwtF_8hbfCjr__6vLcS6XngB_UlwddpPLZlqLpHL3-uKFc_3A~912f4228d933af904c5adc8e65aaf8e4
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
39.2
NOK
Average target price
57
NOK
Spread / Average Target
+45.41%
High Price Target
57
NOK
Spread / Highest target
+45.41%
Low Price Target
57
NOK
Spread / Lowest Target
+45.41%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- GENT Stock
- Consensus Gentian Diagnostics